Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

382

Participants

Timeline

Start Date

February 5, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

proton pump inhibitor

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

DRUG

Amoxicillin

antibiotic for H. pylori eradication

DRUG

Clarithromycin

antibiotic for H. pylori eradication

DRUG

Metronidazole

antibiotic for H. pylori eradication

DRUG

Levofloxacin

antibiotic for H. pylori eradication

Trial Locations (5)

200001

Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

Shanghai General Hospital, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai

Shanghai Tenth People's Hospital, Tongji University, Shanghai

Zhongshan Hospital,Fudan University, Shanghai

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02935010 - Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment | Biotech Hunter | Biotech Hunter